What happened in the world of GMP regulations in 2024? Looking at the highlights of the year, it was a year full of exciting developments. From new regulations in the German Medicines Act (AMG) and the German ordinance for the manufacture of medicinal products and active pharmaceutical ingredients (AMWHV) toclarifications to Annex 1 and training material for ICH Q9(R1) Quality Risk Management.

Planned changes to the EU GMP Guide have been published by the EMA. The nitrosamine issue remains a constant topic that continues to occupy pharmaceutical manufacturers, and will not have lost any of its relevance by 2024. But that's not all!

GMP-Verlag has once again produced its comprehensive "Regulatory Review" for 2024, which covers all these topics in detail, including medical devices. The complete document is available from us and provides a valuable overview. What is essential for your own professional environment? Which requirements have yet to be implemented or have even been forgotten? Get an overview of the regulations that are important for your daily business!

Dr Sabine Paris will be at the GMP-Verlag stand to present some of the most important GMP regulatory news 2024.